Turnaround and Transformation Survey

Companies in many regions remain mired in challenges driven by the rapid rise in the cost of capital. Criticaleye Partner AlixPartners' 19th Annual Turnaround and Transformation Survey sees more than 700 of the world's restructuring experts, and executives say that the cost of capital is still the biggest factor driving company distress. However, that is just one part of the emerging story.

Key Takeaways Include:

  • Which sector globally is most likely to face distress in 2024? 
  • 82 percent expect the cost of capital to remain at current levels or increase further, while 18 percent expect it to decrease.
  • 72 percent say restructuring capital structure or moving assets is the most likely liability management technique to be activated in the next 12 months to mitigate risk.




Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.

Click here to download this insight
Inside the Take-private at Pr...

After a whirlwind journey from the NYSE to private ownership, PropertyGuru CFO Joe Dische reflects on making the hard calls. In this interview with Criticaleye Senior Editor Bridgette Hall, he discusses public vs privat...

Inspiring Leaders Podcast: Le...

Rob Hornby, Co-CEO of AlixPartners and Rita Clifton CBE, Portfolio Chair and Non-Executive Director (including Deputy Chair of the John Lewis Partnership, Chair of Simplyhealth, Chair of the international sustainability...

Inspiring Leaders Podcast: De...

Lucinda Charles-Jones, Non-executive Director & Chair or RemCo for Virgin Money and Rank Group (plus a Criticaleye Board Mentor) and Jim Devine, Group HRD, Spirax Group speak to us about some of the findings of our ...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 430




Aldermore Group Eightfold AI FTSE Women Leaders Review Workday Rolls-Royce AlixPartners Worldpay Google Drax Group plc Accenture IBM Consulting Legal & General E.ON UK NatWest Group Concentrix British Land Hitachi Solutions London Stock Exchange Group Palo Alto Networks Lightsource bp NATS GlaxoSmithKline plc Salesforce